Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolabs is celebrating its 29th year...
15
Jun
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agilex has extensive experience de...
Agilex has extensive experience developing and validating like-binding assays for specific immune-oncology therapeutics. From a...
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology studies? There are many ben...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
by Kurt Sales The rise of Cell and Gene Therapy products is increasingly becoming more prevalent. At Agilex we are seeing more...
By Dr. Kurt Sales, CSO Section Summary: How Agilex has emerged as a leader to support the rise of natural products, includi...
By Dr. Kurt Sales, CSO Summary The following article focuses on the use of flow cytometry in clinical trials and the use of...
By William Grenfell, Head of IT In today's digital age, information security is paramount. At Agilex Biolabs, we understand the...
By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development industry is at the forefront o...
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy! Agilex Biolabs is thrilled t...
Research shows that Biotechnology companies have been facing significant challenges – with continual declines in deal making act...
By Dr. Kurt Sales, CSO Introduction Immunological assays are essential in drug development, especially for immunomodulatory...
By Dr. Kurt Sales, CSO Peripheral Blood Mononuclear Cells (PBMC) are critical for the pharmacodynamic assessment of new drug pr...
The Role of Peripheral Blood Mononuclear Cells (PBMCs) in Drug Discovery and Clinical Trials. By Dr. Kurt Sales, CSO In the...
By Dr. Kurt Sales, CSO Oligonucleotides, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have gai...
